Drugmaker Eli Lilly says after successful results in a phase 3 clinical trial, it expects to submit a GLP-1 weight loss pill ...

Mason Pfeil looked right at home taking the mound for Johnstown-2 Martella’s Pharmacy in Pool B action against the Buffalo East Coast Orville’s Wednesday afternoon at Sargent’s Stadium at the Point in ...

The summer heat may be the focus for many in Holland this August, but anticipation is growing for the more than $11 million ...

Despite progress on several clinical programs and tighter cost controls, there was a major decline in cash reserves, with cash and cash equivalents (GAAP) decreasing from $49.0 million as of December ...

Tampa City Council approved a resolution a $1.83 million contract to begin repairs at Sulphur Springs Pool. FOX 13's Kylie ...

Net debt and capitalization -- $6.9 million in cash as of June 30, 2025, $6.6 million in debt facilities available as of June ...

More than one million gallons of hazardous pollutants have been removed from the USS Yorktown as a years-long environmental ...

Now, new clinical trial results suggest that an oral form of this medication may be coming soon—and the results so far are ...

Norris must not only sustain his form but also navigate the increasingly tense dynamics within the McLaren garage.

Q2 2025 Management View CEO Rodney Tyler Page highlighted that Cipher "delivered on all previously outlined plans at Black ...

Eli Lilly's experimental GLP-1 pill shows promise in a Phase Three trial, helping users lose an average of 12% of body weight ...

Lilly's weight-loss medications Mounjaro and Zepbound are gaining market share on Novo's Wegovy and Ozempic, but investors ...